New research suggests that people who stop using blockbuster weight-loss injections like semaglutide or tirzepatide may regain shed pounds much more quickly than those who halt conventional diet and exercise plans.
Findings released in a major medical journal demonstrates that while obese people can lose about a fifth of their total mass while using the jabs, the weight comes back at an estimated rate of nearly a kilo each month after stopping.
"People purchasing such drugs must be informed of the potential of rapid weight regain when the therapy is stopped," stated lead investigator Dr. Susan Jebb.
That rate of recovery suggests a reversion to starting weight in about 18 months.
Weighing Therapies
The analysis, which looked at dozens of studies involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with other pills.
Scientists emphasize that people who shed pounds through dieting usually see a less rapid creep back—perhaps 100 grams monthly—after stopping.
Understanding the Rapid Regain
Doctors believe the way of the injections is key to understanding the accelerated weight return.
These medications copy a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Long-term administration of GLP-1 concentrations far above than the body's typical production may cause the body to generate a reduced amount of its endogenous hormone, and could reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.
"Discontinuation of this hormone supplement leads to appetite is unsuppressed, making excessive eating a significant risk."
A Lifelong Disease?
Health authorities recommend the injections for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes.
A number of clinicians contend that, given the high risk of weight regain, the treatment is often long-term.
This perspective is echoed by drug manufacturers, who state that the results "highlight the persistent character of obesity," similar to managing conditions like hypertension.
Patient Testimonies
Individuals who have discontinued the jabs explain a intense return of cravings.
"It was like something flipping and I was suddenly ravenous," said an individual.
This difficulty is worsened if patients have not adopted permanent dietary or behavioural modifications during therapy.
Growing Adoption
Figures indicate that millions of adults in the UK have used these injections in the last 12 months, with desire continuing to grow.
- Use is higher among women compared to males.
- The 40s and 50s age group shows the greatest usage rates.
- Many obtain the medications through private healthcare rather than public health services.
Finally, researchers stress that while the jabs are potent agents for weight loss, they are not a magic fix and lasting health benefits hinges on integrated lifestyle management.
